[Errors about SBU statement and atenolol].
Rehnqvist
Nina
N
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol